Protocol: PK Bridging ELISA for Use with Anti-Vedolizumab Antibodies

Reagents

BSA
HISPEC Assay Diluent (BUF049)
Human Serum (Sigma-Aldrich, H4522)
LYNX Rapid HRP Antibody Conjugation Kit® (LNK001P-LNK006P)

PBS

136 mM NaCl
2.68 mM KCl
8.1 mM Na₂HPO₄
1.46 mM KH₂PO₄

PBST

PBS with 0.05% Tween-20

QuantaBlu Fluorogenic Peroxidase Substrate (Thermo Fisher Scientific, 15169)

Materials

384-well microtiter plate, black, square flat-bottom wells, for example, Black 384-Well Immuno Plates (Thermo Fisher Scientific, 460518)

Fluorescence plate reader

96-well plates can be used instead of 384-well plates, (black, flat-bottom wells) for example, Black 96-Well Immuno Plates (Thermo Fisher Scientific, 437111). For the 96-well format, use 100 μl (instead of 20 μl) of antigen, antibodies, or substrate and 300 μl for the blocking step.

Method

1. Prepare the detection Anti-Vedolizumab Antibody: conjugate HCA293 (AbD30136_hIgG1), HCA294 (AbD30138_hIgG1) or HCA295 (AbD30139_hIgG1) using a LYNX Rapid HRP Antibody Conjugation Kit. Anti-Vedolizumab Antibody HCA294P is already conjugated to HRP.
2. Prepare the capture Anti-Vedolizumab Antibody HCA292 (AbD30136) at 1 μg/ml in PBS. Coat the required number of wells of a 384-well microtiter plate with 20 μl per well of the prepared capture antibody, and incubate overnight at 4°C.
3. Wash the microtiter plate five times (5x) with PBST.
4. Block the microtiter plate by adding 100 μl 5% BSA in PBST to each well, and then incubate for 1 hr at RT.
5. Wash the microtiter plate 5x with PBST.
6. For the standard curve, prepare a dilution series of vedolizumab in 10% human serum in PBST in triplicate. Final concentration of vedolizumab should cover the range from 0.01 ng/ml to 4,000 ng/ml. Include a zero vedolizumab concentration as the background value.
7. Add 20 μl of vedolizumab dilution per well (in triplicate for each standard recommended). Add 20 μl of each test sample to the other wells (in triplicate for each sample recommended). Incubate for 1 hr at RT.
8. Wash the microtiter plate 5x with PBST.
9. To each well, add 20 μl HRP conjugated detection Anti-Vedolizumab Antibody, HCA293 (AbD30136_hIgG1), HCA294, HCA294P (AbD30138_hIgG1), or HCA295 (AbD30139_hIgG1), at 2 μg/ml in HISPEC Assay Diluent. Incubate for 1 hr at RT.
10. Wash the microtiter plate 10x with PBST.
11. Add 20 μl QuantaBlu Fluorogenic Peroxidase Substrate to each well and measure the fluorescence after 30 min.